Algorae Pharmaceuticals Limited (ASX:1AI)
Australia
· Delayed Price · Currency is AUD
0.0130
-0.0010 (-7.14%)
Mar 10, 2026, 4:10 PM AEST
Algorae Pharmaceuticals Cash Flow Statement
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
| TTM
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
| Net Income | -1.01 | -0.8 | -2.1 | -2.11 | -1.96 | -1.46 | |
| Depreciation & Amortization | - | - | - | 0 | 0 | 0.05 | |
| Loss (Gain) From Sale of Assets | - | - | 0 | - | 0.01 | - | |
| Loss (Gain) From Sale of Investments | - | - | - | - | - | -0.11 | |
| Stock-Based Compensation | 0.04 | 0.04 | 0.77 | 0 | -0.04 | -0.05 | |
| Other Operating Activities | 0.28 | -0.01 | 0.01 | 0.02 | -0.01 | 0 | |
| Change in Accounts Receivable | 0.01 | 0.01 | 0.05 | -0.07 | -0.02 | 0.09 | |
| Change in Accounts Payable | -0.02 | -0.02 | -0.18 | 0.16 | 0.03 | -0.03 | |
| Change in Other Net Operating Assets | 0.01 | 0.01 | -0.09 | 0.01 | -0.05 | 0.04 | |
| Operating Cash Flow | -0.7 | -0.79 | -1.52 | -1.99 | -2.04 | -1.46 | |
| Capital Expenditures | - | - | - | - | -0 | - | |
| Investment in Securities | 1.35 | 0.45 | -0.28 | 0.98 | - | 0.11 | |
| Other Investing Activities | - | - | - | - | 0.04 | - | |
| Investing Cash Flow | 1.35 | 0.45 | -0.28 | 0.98 | 0.04 | 0.11 | |
| Long-Term Debt Repaid | - | - | - | - | - | -0.04 | |
| Net Debt Issued (Repaid) | - | - | - | - | - | -0.04 | |
| Issuance of Common Stock | 0 | - | 0.57 | 2.15 | 5.15 | - | |
| Other Financing Activities | 0.18 | -0 | -0.05 | -0.3 | -0.46 | - | |
| Financing Cash Flow | 0.18 | -0 | 0.52 | 1.85 | 4.69 | -0.04 | |
| Foreign Exchange Rate Adjustments | -0 | -0 | -0 | 0.01 | -0.01 | 0 | |
| Net Cash Flow | 0.83 | -0.34 | -1.28 | 0.85 | 2.67 | -1.4 | |
| Free Cash Flow | -0.7 | -0.79 | -1.52 | -1.99 | -2.05 | -1.46 | |
| Free Cash Flow Margin | - | - | - | - | -60088.31% | -544.97% | |
| Free Cash Flow Per Share | - | - | -0.00 | -0.00 | -0.00 | -0.00 | |
| Levered Free Cash Flow | -0.7 | -0.64 | -0.56 | -0.8 | -1 | -0.73 | |
| Unlevered Free Cash Flow | -0.7 | -0.63 | -0.56 | -0.8 | -1 | -0.73 | |
| Change in Working Capital | -0 | -0 | -0.21 | 0.1 | -0.04 | 0.1 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.